Literature DB >> 30664787

Therapy resistance beyond cellular dormancy.

Melanie Werner-Klein1,2, Christoph A Klein3,4.   

Abstract

Mesh：

Year:  2019        PMID： 30664787     DOI： 10.1038/s41556-019-0276-7

Source DB:  PubMed          Journal:  Nat Cell Biol        ISSN： 1465-7392            Impact factor:   28.824


× No keyword cloud information.
  1 in total

1.  Targeting the perivascular niche sensitizes disseminated tumour cells to chemotherapy.

Authors:  Patrick Carlson; Arko Dasgupta; Candice A Grzelak; Jeanna Kim; Alexander Barrett; Ilsa M Coleman; Ryann E Shor; Erica T Goddard; Jinxiang Dai; Emma M Schweitzer; Andrea R Lim; Sarah B Crist; David A Cheresh; Peter S Nelson; Kirk C Hansen; Cyrus M Ghajar
Journal:  Nat Cell Biol       Date:  2019-01-21       Impact factor: 28.824
  1 in total
  4 in total

Review 1.  KISS1 in metastatic cancer research and treatment: potential and paradoxes.

Authors:  Thuc Ly; Sitaram Harihar; Danny R Welch
Journal:  Cancer Metastasis Rev       Date:  2020-09       Impact factor: 9.264

Review 2.  Cancer progression and the invisible phase of metastatic colonization.

Authors:  Christoph A Klein
Journal:  Nat Rev Cancer       Date:  2020-10-06       Impact factor: 60.716

3.  Dormancy and NKG2D system in brain metastases: Analysis of immunogenicity.

Authors:  Charlotte Flüh; Victor Mafael; Vivian Adamski; Michael Synowitz; Janka Held-Feindt
Journal:  Int J Mol Med       Date:  2019-12-30       Impact factor: 4.101

Review 4.  A Perspective on Therapeutic Pan-Resistance in Metastatic Cancer.

Authors:  Dimitrios Korentzelos; Amanda M Clark; Alan Wells
Journal:  Int J Mol Sci       Date:  2020-10-03       Impact factor: 5.923
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.